The Canadian Press on MSN1d
TPH saw ‘many deviations’ at gynecologist’s clinic with potential HIV, hepatitis exposure
Toronto Public Health says it observed “many deviations from best practices” during an inspection at the gynecologist's ...
The Canadian Press on MSN5d
Potential HIV, hepatitis exposure at Toronto gynecology clinic has patients worried
The letter said patients who received endometrial biopsies, IUD insertions or had cervical growths removed at the clinic ...
STAT3d
HIV self-testing is easy, effective — and underutilized
HIV self-testing remains underutilized among not only the general public, but especially people who use drugs.
MIT Technology Review2d
This annual shot might protect against HIV infections
Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
The Lancet5d
The potential for annual long-acting HIV pre-exposure prophylaxis
Pre-exposure prophylaxis (PrEP) is the advent of antiretroviral treatment use for people at increased risk of acquiring HIV-1 ...
Gilead plots trial of groundbreaking, once-a-year HIV prevention drug lenacapavir
Bay Area drug giant Gilead is plotting the trial of a groundbreaking, once-a-year HIV prevention drug lenacapavir.
Devdiscourse5d
Yearly HIV Injection Shows Promise in Prevention Efforts
A clinical trial published in The Lancet suggests that a yearly injection of lenacapavir, developed by Gilead Sciences, is ...
Reformulation of HIV prevention drug lenacapavir makes it last for a year
A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV ...
Study examines a novel way to bring addiction care and HIV prevention to people who inject drugs
Researchers from the HIV Prevention Trials Network (HPTN) have presented results from the HPTN 094 ("INTEGRA") study at the ...